↓ Cooling
Business
In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment
The FDA has issued a complete response letter rejecting ITM's radiopharmaceutical therapy ITM-11, a drug positioned to compete with Novartis treatments.